ES2136659T3 - Procedimiento de secado por pulverizacion de aminoguanidina. - Google Patents

Procedimiento de secado por pulverizacion de aminoguanidina.

Info

Publication number
ES2136659T3
ES2136659T3 ES93909154T ES93909154T ES2136659T3 ES 2136659 T3 ES2136659 T3 ES 2136659T3 ES 93909154 T ES93909154 T ES 93909154T ES 93909154 T ES93909154 T ES 93909154T ES 2136659 T3 ES2136659 T3 ES 2136659T3
Authority
ES
Spain
Prior art keywords
aminoguanidine
spray drying
drying procedure
compatible
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93909154T
Other languages
English (en)
Inventor
Phillip E Page
Jonathan Berman
Janet M Pence
Sharon K Minish
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synvista Therapeutics Inc
Original Assignee
Alteon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alteon Inc filed Critical Alteon Inc
Application granted granted Critical
Publication of ES2136659T3 publication Critical patent/ES2136659T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA TABLETA COMPRIMIDA QUE COMPRENDE AMINOGUANIDINA O UNA SAL DE ELLO ACEPTABLE FARMACEUTICAMENTE Y UN AGLUTINANTE COMPATIBLE CONVENIENTEMENTE PREPARADO POR TECNICAS DE SECADO PULVERIZANTES DE UNA SOLUCION AMINOGUANIDINA, Y METODOS PARA REALIZAR EL MISMO
ES93909154T 1992-04-15 1993-03-24 Procedimiento de secado por pulverizacion de aminoguanidina. Expired - Lifetime ES2136659T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86955892A 1992-04-15 1992-04-15

Publications (1)

Publication Number Publication Date
ES2136659T3 true ES2136659T3 (es) 1999-12-01

Family

ID=25353792

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93909154T Expired - Lifetime ES2136659T3 (es) 1992-04-15 1993-03-24 Procedimiento de secado por pulverizacion de aminoguanidina.

Country Status (21)

Country Link
US (1) US5534551A (es)
EP (1) EP0636023B1 (es)
JP (1) JPH07505654A (es)
KR (1) KR950700730A (es)
AR (1) AR248350A1 (es)
AT (1) ATE183086T1 (es)
AU (1) AU665678B2 (es)
CA (1) CA2118133C (es)
DE (1) DE69325996T2 (es)
DK (1) DK0636023T3 (es)
ES (1) ES2136659T3 (es)
FI (1) FI944855A (es)
GR (1) GR3031486T3 (es)
HU (1) HUT70870A (es)
IL (1) IL105363A (es)
MX (1) MX9302153A (es)
NO (1) NO943899L (es)
NZ (1) NZ251806A (es)
TW (1) TW261538B (es)
WO (1) WO1993020808A1 (es)
ZA (1) ZA932595B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093745A (en) * 1997-11-25 2000-07-25 Psorx, L.L.C. Methods and composition for treating skin proliferative diseases
US6294198B1 (en) 1999-08-24 2001-09-25 Purepac Pharmaceutical Co. Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
US20030206978A1 (en) * 2001-11-29 2003-11-06 Bob Sherwood Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
DE202013102188U1 (de) 2013-05-17 2013-06-12 Che-An Tsai Anordnung einer trocken aufhängbaren Dünnstein-Wandbauplatte
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3621056A (en) * 1968-08-16 1971-11-16 Sandoz Ag Substituted benzylideneamino guanidines
DE2015321A1 (en) * 1969-04-04 1970-10-08 Sandoz Ag, Basel (Schweiz) Novel guanidine derivs
US3714363A (en) * 1970-08-11 1973-01-30 Sandoz Ag Substituted amino guanidine as anti-diabetic agents
US3659016A (en) * 1971-04-26 1972-04-25 Sandoz Ag Substituted amino guanidines as anti-obesity agents
NL7317772A (es) * 1973-01-04 1974-07-08
DE2736064A1 (de) * 1977-08-10 1979-02-22 Bayer Ag Antimalaria-mittel
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
DE3135329A1 (de) * 1981-09-05 1983-03-24 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen
US4605666A (en) * 1983-10-24 1986-08-12 Basf Corporation Process for preparing spray-dried powders containing a water-soluble vitamin and powders prepared thereby
US4533674A (en) * 1983-10-24 1985-08-06 Basf Wyandotte Corporation Process for preparing a sugar and starch free spray-dried vitamin C powder containing 90 percent ascorbic acid
US4758583A (en) * 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4916163A (en) * 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide
US4710519A (en) * 1985-09-30 1987-12-01 Basf Corporation Process for preparing spray dried acetaminophen powder and the powder prepared thereby
US4892889A (en) * 1986-11-18 1990-01-09 Basf Corporation Process for making a spray-dried, directly-compressible vitamin powder comprising unhydrolyzed gelatin
EP0339496A3 (en) * 1988-04-26 1991-05-08 Ono Pharmaceutical Co., Ltd. Aminoguanidine derivatives
US5077313A (en) * 1988-11-25 1991-12-31 Gert Lubec Process for inhibiting pathological collagen cross-linking in diabetes patients
US5002774A (en) * 1989-06-08 1991-03-26 Erbamont, Inc. Sustained release pharmaceutical tablet
PT96229B (pt) * 1989-12-22 1998-06-30 Syntex Pharma Int Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico

Also Published As

Publication number Publication date
NZ251806A (en) 1996-01-26
DE69325996D1 (de) 1999-09-16
CA2118133C (en) 1997-01-21
FI944855A0 (fi) 1994-10-14
GR3031486T3 (en) 2000-01-31
ATE183086T1 (de) 1999-08-15
MX9302153A (es) 1994-05-31
WO1993020808A1 (en) 1993-10-28
ZA932595B (en) 1993-10-26
US5534551A (en) 1996-07-09
HU9402981D0 (en) 1995-02-28
DK0636023T3 (da) 1999-12-06
KR950700730A (ko) 1995-02-20
AU665678B2 (en) 1996-01-11
HUT70870A (en) 1995-11-28
JPH07505654A (ja) 1995-06-22
AU3966793A (en) 1993-11-18
NO943899D0 (no) 1994-10-14
TW261538B (es) 1995-11-01
DE69325996T2 (de) 1999-12-23
FI944855A (fi) 1994-10-14
EP0636023A1 (en) 1995-02-01
NO943899L (no) 1994-12-14
IL105363A0 (en) 1993-08-18
IL105363A (en) 1997-07-13
EP0636023B1 (en) 1999-08-11
AR248350A1 (es) 1995-08-18

Similar Documents

Publication Publication Date Title
MX9206306A (es) Peptidos, procedimiento para su produccion y composicion farmaceutica que los contiene.
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
DE69122988D1 (de) Niederdruck-Spritzpistole
MX9201141A (es) Ciclosporinas cristalinas, procedimiento para su produccion y composicion farmaceutica que las contiene.
ES2145254T3 (es) Formulaciones de aerosoles que contienen flunisolida.
NO910333D0 (no) Fremgangsmaate for plasmasprengning.
ES2175127T3 (es) Derivados de la quinazolina y su uso.
NL300281I2 (nl) Exenatide, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
AR042345A2 (es) Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma
BR8902256A (pt) Cabeca pulverizadora para embalabem aerossol
DK0840606T3 (da) Små di- og trivalente molekyler som selectininhibitorer
DE69110468D1 (de) Hochdrucksprühkopf.
DE69206008D1 (de) Pneumatische Spritzpistole.
ES2136659T3 (es) Procedimiento de secado por pulverizacion de aminoguanidina.
ES2177103T3 (es) Terapia de combinacion para el tratamiento del sida.
DE59102069D1 (de) Druckzerstäuber.
DE68916547D1 (de) Diffusionsversprüher für aerosol.
ES2184121T3 (es) Formulacion para el tratamiento y/o profilaxis de la demencia.
DK0675766T3 (da) Sprøjtepistol til højtryksrenser
ES1004653Y (es) Pulverizador perfeccionado para atomizadores.
ES2063014T3 (es) Derivados de 2-oxa-isocefemo, composiciones que los contienen y procedimientos de preparacion.
MX9201912A (es) Nuevas sulfonamidas, procedimiento para su preparacion y preparado farmaceutico que las contiene.
DK602787D0 (da) Sproejtelanse, navnlig til hoejtryksrensere
DE68910505D1 (de) Schnüffelventilanordnung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 636023

Country of ref document: ES